Understand the source comparison
Best Peptides for Diverticulitis: Research Comparison
BPC-157 VEGF upregulation, NO pathway modulation, mucosal healing Accelerated colonic anastomosis healing, reduced inflammatory infiltrates in colitis models (Journal of Physiology-Paris) Intraperitoneal, oral, topical Limited human trials; dosing extrapolatio
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- VEGF upregulation, NO pathway modulation, mucosal healing
- Accelerated colonic anastomosis healing, reduced inflammatory infiltrates in colitis models (Journal of Physiology-Paris)
- Intraperitoneal, oral, topical
- Limited human trials; dosing extrapolation from rodent models unclear
- Strong preclinical evidence for barrier repair; most studied peptide for GI injury
- KPV
- NF-κB inhibition, mucin restoration, localized anti-inflammatory signaling
- 40–60% reduction in colitis severity scores, 35% improvement in intestinal permeability (PLOS ONE, Molecular Medicine)
- Oral, rectal
- Rapid degradation in gastric acid limits oral bioavailability
- Excellent safety profile; rectal administration may be optimal for colonic targeting
- Thymosin Beta-4
- Actin sequestration, laminin-5 upregulation, cell migration promotion
- Reduced fibrosis and collagen deposition in chronic colitis, accelerated re-epithelialization (Gut, AJP)
- Subcutaneous, intraperitoneal
- High cost; less data on acute inflammation vs chronic repair
- Best suited for preventing long-term structural complications (strictures, fibrosis)
- Thymalin
- Thymic peptide immune modulation, T-cell regulation
- Improved immune homeostasis in mucosal immunity studies
- Subcutaneous
- Indirect mechanism; works through systemic immune regulation rather than local gut action
- Thymalin may support broader immune balance but lacks direct gut-specific data